Gut microbes effects on host metabolic alterations in health and disease

References

• Adeshirlarijaney A, Gewirtz AT. Considering gut microbiota in treatment of type 2 diabetes mellitus. Gut Microbes. 2020;11(03):253–264. doi:10.1080/19490976.2020.1717719.
   Google Scholar
• Hosomi K, Kiyono H, Kunisawa J. Fatty acid metabolism in the host and commensal bacteria for the control of intestinal immune responses and diseases. Gut Microbes. 2019;11(03):276–284. doi:10.1080/19490976.2019.1612662.
   Google Scholar
• Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014;111(42):E4485–93. doi:10.1073/pnas.1415174111.
   Google Scholar
• Mutlu EA, Gillevet PM, Rangwala H, Sikaroodi M, Naqvi A, Engen PA, Kwasny M, Lau CK, Keshavarzian A. Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol. 2012;302(9):G966–78. doi:10.1152/ajpgi.00380.2011.
   Google Scholar
• Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070–11075. doi:10.1073/pnas.0504978102.
   Google Scholar
• Waldram A, Holmes E, Wang Y, Rantalainen M, Wilson ID, Tuohy KM, McCartney AL, Gibson GR, Nicholson JK. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res. 2009;8:2361–2375. doi:10.1021/pr8009885.
   Google Scholar
• Song M, Chan AT. Diet, gut microbiota, and colorectal cancer prevention: a review of potential mechanisms and promising targets for future research. Curr Colorectal Cancer Rep. 2017;13:429–439. doi:10.1007/s11888-017-0389-y.
   Google Scholar
• Jackson DN, Theiss AL. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes. 2019;11(03):253–264. doi:10.1080/19490976.2019.1592421.
   Google Scholar
• DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200. doi:10.1126/sciadv.1600200.
   Google Scholar
• Kim A. Mitochondria in cancer energy metabolism: culprits or bystanders? Toxicol Res. 2015;31:323–330. doi:10.5487/TR.2015.31.4.323.
   Google Scholar
• Backhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915–1920. doi:10.1126/science.1104816.
   Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031. doi:10.1038/nature05414.
   Google Scholar
• Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104:979–984. doi:10.1073/pnas.0605374104.
   Google Scholar
• Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772. doi:10.2337/db06-1491.
   Google Scholar
• Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328(5975):228–231. doi:10.1126/science.1179721.
   Google Scholar
• Carvalho FA, Koren O, Goodrich JK, Johansson MV, Nalbantoglu I, Aitken J, Su Y, Chassaing B, Walters W, González A, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe. 2012;12(2):139–152. doi:10.1016/j.chom.2012.07.004.
   Google Scholar
• Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi:10.1038/nature11450.
   Google Scholar
• Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. doi:10.1038/nature12198.
   Google Scholar
• Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JFWM, Dallinga–Thie GM, Ackermans MT, Serlie MJ, Oozeer R, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913–6 e7. doi:10.1053/j.gastro.2012.06.031.
   Google Scholar
• de Groot P, Scheithauer T, Bakker GJ, et al. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. Gut. 2020;69:502–512.
   Google Scholar
• Razmpoosh E, Javadi M, Ejtahed H-S, Mirmiran P. Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review. Diabetes Metab Res Rev. 2016;32(2):143–168. doi:10.1002/dmrr.2665.
   Google Scholar
• Bode JC, Bode C, Heidelbach R, Dürr HK, Martini GA. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology. 1984;31:30–34.
   Google Scholar
• Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, Gobejishvili L, Joshi-Barve S, Ayvaz T, Petrosino J, et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One. 2013;8(1):e53028. doi:10.1371/journal.pone.0053028.
   Google Scholar
• Wang L, Fouts DE, Starkel P, Hartmann P, Chen P, Llorente C, DePew J, Moncera K, Ho S, Brenner D, et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe. 2016;19(2):227–239. doi:10.1016/j.chom.2016.01.003.
   Google Scholar
• Bluemel S, Wang L, Kuelbs C, Moncera K, Torralba M, Singh H, Fouts DE, Schnabl B. Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice. Gut Microbes. 2019;11(03):265–275. doi:10.1080/19490976.2019.1595300.
   Google Scholar
• Carta G, Murru E, Banni S, Manca C. Palmitic acid: physiological role, metabolism and nutritional implications. Front Physiol. 2017;8:902. doi:10.3389/fphys.2017.00902.
   Google Scholar
• Baur P, Martin F-P, Gruber L, Bosco N, Brahmbhatt V, Collino S, Guy P, Montoliu I, Rozman J, Klingenspor M, et al. Metabolic phenotyping of the Crohn’s Disease-like IBD etiopathology in the TNF ΔARE/WT mouse model. J Proteome Res. 2011;10(12):5523–5535. doi:10.1021/pr2007973.
   Google Scholar
• Bertin B, Desreumaux P, Dubuquoy L. Obesity, visceral fat and Crohnʼs disease. Curr Opin Clin Nutr Metab Care. 2010;13(5):574–580. doi:10.1097/MCO.0b013e32833cf0f4.
   Google Scholar
• Matsuo S, Yang W-L, Aziz M, Kameoka S, Wang P. Fatty acid synthase inhibitor C75 ameliorates experimental colitis. Mol Med. 2014;20(1):1–9. doi:10.2119/molmed.2013.00113.
   Google Scholar
• Vargas T, Moreno-Rubio J, Herranz J, Cejas P, Molina S, González-Vallinas M, Mendiola M, Burgos E, Aguayo C, Custodio AB, et al. ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients. Oncotarget. 2015;6(9):7348–7363. doi:10.18632/oncotarget.3130.
   Google Scholar
• Currie E, Schulze A, Zechner R, Walther T, Farese R. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–161. doi:10.1016/j.cmet.2013.05.017.
   Google Scholar
• Kawamori T, Kaneshiro T, Okumura M, et al. Role for sphingosine kinase 1 in colon carcinogenesis. Faseb J. 2009;23:405–414. doi:10.1096/fj.08-117572.
   Google Scholar
• Accioly MT, Pacheco P, Maya-Monteiro CM, Carrossini N, Robbs BK, Oliveira SS, Kaufmann C, Morgado-Diaz JA, Bozza PT, Viola JPB, et al. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res. 2008;68:1732–1740. doi:10.1158/0008-5472.CAN-07-1999.
   Google Scholar
• Penrose H, Heller S, Cable C, Makboul R, Chadalawada G, Chen Y, Crawford SE, Savkovic SD. Epidermal growth factor receptor mediated proliferation depends on increased lipid droplet density regulated via a negative regulatory loop with FOXO3/Sirtuin6. Biochem Biophys Res Commun. 2016;469(3):370–376. doi:10.1016/j.bbrc.2015.11.119.
   Google Scholar
• Heller S, Cable C, Penrose H, et al. Intestinal inflammation requires FOXO3 and Prostaglandin E2 dependent lipogenesis and elevated lipid droplets. Am J Physiol Gastrointest Liver Physiol. 2015;2016(ajpgi):00407.
   Google Scholar
• Maya-Monteiro CM, Almeida PE, D’Avila H, et al. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J Biol Chem. 2008;68(4):1732–1740. doi:10.1074/jbc.M706706200.
   Google Scholar
• Qi W, Fitchev PS, Cornwell ML, Greenberg J, Cabe M, Weber CR, Roy HK, Crawford SE, Savkovic SD. FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density. J Biol Chem. 2013;288(23):16274–16281. doi:10.1074/jbc.M113.470617.
   Google Scholar
• Suliman HB, Piantadosi CA, Mattson MP. Mitochondrial Quality Control as a Therapeutic Target. Pharmacol Rev. 2016;68(1):20–48. doi:10.1124/pr.115.011502.
   Google Scholar
• Vyas S, Zaganjor E, Haigis MC. Mitochondria and Cancer. Cell. 2016;166(3):555–566. doi:10.1016/j.cell.2016.07.002.
   Google Scholar
• Boekema EJ, Braun HP. Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem. 2007;282:1–4. doi:10.1074/jbc.R600031200.
   Google Scholar
• Tan J, McKenzie C, Potamitis M, et al. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91–119.
   Google Scholar
• Hsieh S-Y, Shih T-C, Yeh C-Y, Lin C-J, Chou -Y-Y, Lee Y-S. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics. 2006;6(19):5322–5331. doi:10.1002/pmic.200500541.
   Google Scholar
• Sifroni KG, Damiani CR, Stoffel C, Cardoso MR, Ferreira GK, Jeremias IC, Rezin GT, Scaini G, Schuck PF, Dal-Pizzol F, et al. Mitochondrial respiratory chain in the colonic mucosal of patients with ulcerative colitis. Mol Cell Biochem. 2010;342(1–2):111–115. doi:10.1007/s11010-010-0474-x.
   Google Scholar
• Yu X, Wieczorek S, Franke A, Yin H, Pierer M, Sina C, Karlsen TH, Boberg KM, Bergquist A, Kunz M, et al. Association of UCP2 −866 G/A polymorphism with chronic inflammatory diseases. Genes Immun. 2009;10(6):601–605. doi:10.1038/gene.2009.29.
   Google Scholar
• Heller S, Penrose HM, Cable C, Biswas D, Nakhoul H, Baddoo M, Flemington E, Crawford SE, Savkovic SD. Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation. Faseb J. 2017;31(5):2013–2025. doi:10.1096/fj.201600976R.
   Google Scholar
• Ruiz E, Penrose HM, Heller S, Nakhoul H, Baddoo M, Flemington EF, Kandil E, Savkovic SD. Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease. Gut Microbes. 2019;11(03):305–318. doi:10.1080/19490976.2019.1611152.
   Google Scholar
• Chourasia AH, Boland ML, Macleod KF. Mitophagy and cancer. Cancer Metab. 2015;3:4. doi:10.1186/s40170-015-0130-8.
   Google Scholar
• Clark A, Mach N. The Crosstalk between the gut microbiota and mitochondria during exercise. Front Physiol. 2017;8:319. doi:10.3389/fphys.2017.00319.
   Google Scholar
• Li K, Neufer PD, Williams RS. Nuclear responses to depletion of mitochondrial DNA in human cells. Am J Physiol. 1995;269(5):C1265–70. doi:10.1152/ajpcell.1995.269.5.C1265.
   Google Scholar
• Smiraglia DJ, Kulawiec M, Bistulfi GL, Ghoshal S, Singh KK. A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther. 2008;7(8):1182–1190. doi:10.4161/cbt.7.8.6215.
   Google Scholar
• Strickertsson JAB, Desler C, Rasmussen LJ. Bacterial infection increases risk of carcinogenesis by targeting mitochondria. Semin Cancer Biol. 2017;47:95–100. doi:10.1016/j.semcancer.2017.07.003.
   Google Scholar